BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22224173)

  • 21. Prognostic and Therapeutic Implications of Tumor Biology, Including Gene Alterations, in Colorectal Liver Metastases.
    Nishioka Y; Kawaguchi Y; Kothari AN; Odisio BC; Vauthey JN
    J Gastrointest Surg; 2021 Jun; 25(6):1591-1600. PubMed ID: 33742360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
    Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
    Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meeting the biologic challenge of colorectal metastases.
    Wanebo HJ; LeGolvan M; Paty PB; Saha S; Zuber M; D'Angelica MI; Kemeny NE
    Clin Exp Metastasis; 2012 Oct; 29(7):821-39. PubMed ID: 23053740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study.
    Kataoka K; Kanazawa A; Nakajima A; Yamaguchi A; Arimoto A; Kohno Y
    Surg Today; 2013 Oct; 43(10):1154-61. PubMed ID: 23139049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.
    Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J
    Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
    Zimmitti G; Panettieri E; Ardito F; Mele C; Maria V; Rosso E; Nuzzo G; Giuliante F
    Eur J Surg Oncol; 2021 Apr; 47(4):834-841. PubMed ID: 33032866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution in the surgical management of colorectal liver metastases: Propensity score matching analysis (PSM) on the impact of specialized multidisciplinary care across two institutional eras.
    Krüger JAP; Fonseca GM; Makdissi FF; Jeismann VB; Coelho FF; Herman P
    J Surg Oncol; 2018 Jul; 118(1):50-60. PubMed ID: 29878362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy.
    Nikfarjam M; Shereef S; Kimchi ET; Gusani NJ; Jiang Y; Avella DM; Mahraj RP; Staveley-O'Carroll KF
    Ann Surg Oncol; 2009 Jul; 16(7):1860-7. PubMed ID: 19037703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locoregional treatment for colorectal liver metastases aiming for precision medicine.
    Maki H; Jain AJ; Haddad A; Lendoire M; Chun YS; Vauthey JN
    Ann Gastroenterol Surg; 2023 Jul; 7(4):543-552. PubMed ID: 37416742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
    Pietrantonio F; Di Bartolomeo M; Cotsoglou C; Mennitto A; Berenato R; Morano F; Coppa J; Perrone F; Iacovelli R; Milione M; Alessi A; Vaiani M; Bossi I; Ricchini F; Scotti M; Caporale M; Bajetta E; de Braud F; Mazzaferro V
    Clin Colorectal Cancer; 2017 Sep; 16(3):e191-e198. PubMed ID: 27979717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery?
    Adam R; de Haas RJ; Wicherts DA; Vibert E; Salloum C; Azoulay D; Castaing D
    Ann Surg; 2011 Feb; 253(2):349-59. PubMed ID: 21178761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. World review of laparoscopic liver resection-2,804 patients.
    Nguyen KT; Gamblin TC; Geller DA
    Ann Surg; 2009 Nov; 250(5):831-41. PubMed ID: 19801936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeat liver resection for colorectal metastases.
    Kulik U; Bektas H; Klempnauer J; Lehner F
    Br J Surg; 2013 Jun; 100(7):926-32. PubMed ID: 23640669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?
    Brouquet A; Overman MJ; Kopetz S; Maru DM; Loyer EM; Andreou A; Cooper A; Curley SA; Garrett CR; Abdalla EK; Vauthey JN
    Cancer; 2011 Oct; 117(19):4484-92. PubMed ID: 21446046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on chemotherapy of colorectal liver metastases.
    Wang CC; Li J
    World J Gastroenterol; 2012 Jan; 18(1):25-33. PubMed ID: 22228967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S; Poston G
    Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
    Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.